Relationship between morphological diagnosis of NASH (non-alcoholic steatoHepatitis) and liver function test in a group of patients with morbid obesity. Cases study;Relación entre el diagnóstico morfológico de EHNA (esteatohepatitis no alcohólica) y pruebas de función hepática en un grupo de pacientes con obesidad extrema

Revista de Investigacion Clinica

Volumn 57, Issue 4, 2005, Pages 505-512

  Chavarría Arciniega, Sonia ^a   López Alvarenga, Juan Carlos ^a,b   Uribe Uribe, Norma Ofelia ^a   Herrera Hernández, Miguel ^a   González Barranco, Jorge ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cases study; Liver biopsy; Morbid obesity; Non alcoholic steato hepatitis; Transaminasemia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LIVER ENZYME;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BARIATRIC SURGERY; BODY HEIGHT; BODY WEIGHT; BRUNT CLASSIFICATION; CLINICAL ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DYSLIPIDEMIA; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; SEX DIFFERENCE;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BARIATRIC SURGERY; BIOPSY; BODY HEIGHT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FATTY ACIDS; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OBESITY, MORBID; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 27844600189     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Brunt EM. Nonalcoholic steatohepatitis (NASH): further expansion of this clinical entity. Liver 1999; 19: 263-4.
2. Vyberg M, Ravn V, Andersen B. Pattern of progression in liver injury following jejunoileal bypass for morbid obesity. Liver 1987; 7: 271-6.
3. Haines NW, Baker AL, Boyer JL, Glagov S, Schneir H, Jaspan J, Ferguson DJ. Prognostic indicators of hepatic injury following jejunoileal bypass performed for refractory obesity: a prospective study. Hepatology 1981; 1: 161-7.
4. Caldweel SH, Hespenheide EE, Redick JA, Iezzoni JC, Battle EH, Sheppard BL. A pilot study of a thiazolidinedione, Troglitazone, in nonalcoholic steatohepatitis. AJG 2001; 96: 519-24.
5. Hedley AA, Ogden CL, Johnson CL, Carrol MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents and adults, 1999-2002. JAMA 2004; 291: 2847-50.
6. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: and autopsy analysis with analysis of risk factors. Hepatology 1990; 12: 1106-10.
7. Sanyal AJ, Campell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92.
8. Powell EE, Cooksley GE, Hanson R, Searle J, Halliday JW, Powwel LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 1990; 11: 74-80.
9. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastrol 1999; 94: 1018-22.
10. O'connor BJ. Nonalcoholic fatty liver (NASH syndrome). Gastroenterologist 1997; 5: 316-29.
11. Angulo P, Keach JC, Batts KP, Lindor KD, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-62.
12. Burt AD. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 1998; 15: 246-58.
13. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic Steatohepatitis: a proposal for grading and staging the histological lesions. AJG 1999; 94: 2467-74.
14. Teli MR, James OFW, Burt AD, Bennett BM, Day CP. The natural History of nonalcoholic fatty liver: a Follow-up study. Hepatology 1995; 22: 1714-19.
15. Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, Mcgill DB. Ursodeoxycholic acid or clofibrate in the treatment of non-alcoholic-induced steatohepatitis: a pilots study. Hepatology 1996; 23: 1464-7.
16. Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 1991; 12: 224-9.
17. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clinic Proc 1980; 55: 434-8
18. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
19. Cohen H, González M, Ramírez M. Etiología y diagnóstico de la esteatosis hepática. Rev Med Uruguay 1997; 13: 4-11.
20. Sheyh SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126: 137-45.
21. Rodríguez HH, Ruiz MB, González JL, Martínez AG, Panduro CA. Características clínicas e histológicas de pacientes con esteatohepatitis no alcohólica. Rev Gastroenterol Mex 2000; 65:64
22. Neuschwander-tetri BA, Bacon BR. Management of Chronic Liver Disease. Nonalcoholic steatohepatitis, Med Clin North Am 1996; 5:
23. Bernal-Reyes R, Saenz-Labra A. Bernardo-Escudero R. Prevalence of non-alcoholic steatohepatitis. Comparative study with diabetic patients. Rev Gastroenterol Mex 2000; 65(2): 5862.
24. Fernald LC, Gutierrez JP, Neufeld LM, Olaiz G, Bertozzi SM, Mietus-Snyder M, Gertler PJ, High prevalence of obesity among the poor in Mexico. JAMA 2004; 291(21): 2544-5.
25. Aguilar-Salinas CA, Velazquez MO, Gomez-Perez FJ, Gonzalez CA, Esqueda AL, Molina Cuevas V, Rull-Rodrigo JA, Tapia Conyer R. Encuesta Nacional de Salud 2000 Group. Characteristics of patients with type 2 diabetes in México: Results from a large population-based nationwide survey. Diabetes Care 2003; 26(7): 2021-6.
26. Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, Valles V, Rios-Torres JM, Franco A, Olaiz G, Rull JA, Sepulveda J. High prevalence of metabolic syndrome in Mexico. Arch Med Res 2004; 35(1): 76-81.